The susceptibility of lipoprotein(a) to copper oxidation is correlated with the susceptibility of autologous low density lipoprotein to oxidation

Clinical Biochemistry

Volumn 36, Issue 2, 2003, Pages 113-120

  Nakajima, Kei ^a   Yamashita, Takeshi ^b   Kusuhara, Masatoshi ^a   Yonemura, Atsushi ^a   Ito, Toshimitsu ^a   Higashi, Kenji ^a   Ayaori, Makoto ^a   Ohmori, Reiko ^a   Nakamura, Haruo ^b   Ohsuzu, Fumio ^a  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^b Mitsukoshi Health and Welfare Foundation   (Japan)

Author keywords

Apo(a) size; LDL; Lp(a); Oxidation; Susceptibility

Indexed keywords

COPPER; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN;

ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CORRELATION ANALYSIS; ELECTROPHORETIC MOBILITY; HUMAN; MOLECULAR SIZE; NORMAL HUMAN; OXIDATION; PRIORITY JOURNAL; PROTEIN DEGRADATION;

EID: 0037333354     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9120(02)00438-1     Document Type: Article

References (36)

1. Rosengren A., Wilhelmsen L., Eriksson E., Risberg B., Wedel H. Lipoprotein (a), and coronary heart disease a prospective case-control study in a general population sample of middle aged men . BMJ. 301:1990;1248-1251.
2. Sandkamp M., Funke H., Schulte H., Kohler E., Assmann G. Lipoprotein(a) is an independent risk factor for myocardial infarction at a young age. Clin Chem. 36:1990;20-23.
3. Orth-Gomer K., Mittleman M.A., Schenck-Gustafsson K., et al. Lipoprotein(a) as a determinant of coronary heart disease in young women. Circulation. 95:1997;329-334.
4. McLean J.W., Tomlinson J.E., Kuang W.J., et al. cDNA sequence of human apolipoprotein(a) is homologous to plasminogen. Nature. 330:1987;132-137.
5. Lackner C., Cohen J.C., Hobbs H.H. Molecular definition of the extreme size polymorphism in apolipoprotein(a). Hum Mol Genet. 2:1993;933-940.
6. Van der Hoek Y.Y., Wittekoek M.E., Beisiegel U., Kastelein J.J., Koschinsky M.L. The apolipoprotein(a) kringle IV repeats which differ from the major repeat kringle are present in variably-sized isoforms. Hum Mol Genet. 2:1993;361-366.
7. Krauss R.M. Heterogeneity of plasma low-density lipoproteins and atherosclerosis risk. Curr Opin Lipidol. 5:1994;339-349.
8. Devaraj S., Jialal I. Oxidized low-density lipoprotein and atherosclerosis. Int J Clin Lab Res. 26:1996;178-184.
9. Ballantyne C.M. Low-density lipoproteins and risk for coronary artery disease. Am J Cardiol. 82:1998;3Q-12Q.
10. Utermann G., Weber W. Protein composition of Lp(a) lipoprotein from human plasma. FEBS Lett. 154:(2):1983;357-361.
11. Fless G.M., Rolih C.A., Scanu A.M. Heterogeneity of human plasma lipoprotein (a). Isolation and characterization of the lipoprotein subspecies and their apoproteins. J Biol Chem. 259:1984;11470-11478.
12. Rainwater D.L., Ludwig M.J., Haffner S.M., VandeBerg J.L. Lipid and lipoprotein factors associated with variation in Lp(a) density. Arterioscler Thromb Vasc Biol. 15:1995;313-319.
13. Nakajima K., Hinman J., Pfaffinger D., Edelstein C., Scanu A.M. Changes in plasma triglyceride levels shift lipoprotein(a) density in parallel with that of LDL independently of apolipoprotein(a) size. Arterioscler Thromb Vasc Biol. 21:2001;1238-1243.
14. Gries A., Gries M., Wurm H., et al. Lipoprotein(a) inhibits collagen-induced aggregation of thrombocytes. Arterioscler Thromb Vasc Biol. 16:1996;648-655.
15. Edelstein C., Shapiro S.D., Klezovitch O., Scanu A.M. Macrophage metalloelastase, MMP-12, cleaves human apolipoprotein(a) in the linker region between kringles IV-4 and IV-5. Potential relevance to lipoprotein(a) biology. J Biol Chem. 274:1999;10019-10023.
16. Steinberg D. Low density lipoprotein oxidation and its pathobiological significance. J Biol Chem. 272:1997;20963-20966.
17. Esterbauer H., Gebicki J., Puhl H., Jurgens G. The role of lipid peroxidation and antioxidants in the oxidative modification of LDL. Free Radic Biol Med. 13:1992;341-390.
18. Edelstein C., Nakajima K., Pfaffinger D., Scanu A.M. Oxidative events cause degradation of apolipoprotein B100 but not of apolipoprotein (a) and facilitate enzymatic cleavage of both proteins. J Lipid Res. 42:2001;1664-1670.
19. Havel R.J., Eder H.A., Bragdon J.D. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest. 34:1955;1345-1353.
20. Lowry O.H., Rosebrough N.J., Farr A., Randall R.J. Protein measurement with the Folin phenol reagent. J Biol Chem. 193:1951;265-275.
21. Kleinveld H.A., Hak-Lemmers H.L., Stalenhoef A.F., Demacker P.N. Improved measurement of low-density-lipoprotein susceptibility to copper-induced oxidation application of a short procedure for isolating low-density lipoprotein . Clin Chem. 38:1992;2066-2072.
22. McDowell I.F., McEneny J., Trimble E.R. A rapid method for measurement of the susceptibility to oxidation of low-density lipoprotein. Ann Clin Biochem. 32:1995;167-174.
23. Friedewald W.T., Levy R.I., Fredrickson D.S. Estimation of the distribution of low density lipoprotein cholsterol in plasma without the use of the preparative centrifuge. Clin Chem. 18:1972;499-502.
24. Abe A., Yoshimura Y., Sekine T., Maeda S., Yamashita S., Noma A. Fully mechanized latex immunoassay for serum lipoprotein(a). Clin Chim Acta. 225:1994;105-113.
25. Sattler W., Kostner G.M., Waeg G., Esterbauer H. Oxidation of lipoprotein Lp(a). A comparison with low-density lipoproteins. Biochim Biophys Acta. 1081:1991;65-67.
26. Naruszewicz M., Selinger E., Davignon J. Oxidative modification of lipoprotein(a) and the effect of beta-carotene. Metabolism. 41:1992;1215-1224.
27. Beaudeux J.L., Gardes-Albert M., Delattre J., Legrand A., Rousselet F., Peynet J. Resistance of lipoprotein(a) to lipid peroxidation induced by oxygenated free radicals produced by gamma radiolysis a comparison with low-density lipoprotein . Biochem J. 314:1996;277-284.
28. Ragab M.S., Selvaraj P., Sgoutas D.S. Oxidized lipoprotein (a) induces cell adhesion molecule Mac-1 (CD 11b) and enhances adhesion of the monocytic cell line U937 to cultured endothelial cells. Atherosclerosis. 123:(1-2):1996;103-113.
29. Kleinveld H.A., Duif P.F., Pekelharing H.L., van Rijn H.J. Oxidation of lipoprotein(a) and low density lipoprotein containing density gradient ultracentrifugation fractions. Biochim Biophys Acta. 1303:1996;15-21.
30. Hermann A., Laws W.R., Harpel P.C. Oxidation of apolipoprotein(a) inhibits kringle-associated lysine binding the loss of intrinsic protein fluorescence suggests a role for tryptophan residues in the lysine binding site . Protein Sci. 6:1997;2324-2335.
31. Hopkins P.N., Hunt S.C., Schreiner P.J., et al. Lipoprotein(a) interactions with lipid and non-lipid risk factors in patients with early onset coronary artery disease results from the NHLBI Family Heart Study . Atherosclerosis. 141:1998;333-345.
32. Hobbs H.H., White A.L. Lipoprotein(a) intrigues, and insights . Curr Opin Lipidol. 10:1999;225-236.
33. Scanu A.M., Nakajima K., Edelstein C. Apolipoprotein(a) structure, and biology . Front Biosci. 6:2001;D546-554.
34. Beisiegel U., Niendorf A., Wolf K., Reblin T., Rath M. Lipoprotein(a) in the arterial wall. Eur Heart J. 11:(Suppl E):1990;174-183.
35. Iskra M., Patelski J., Majewski W. Relationship of calcium, magnesium, zinc and copper concentrations in the arterial wall, and serum in atherosclerosis obliterans, and aneurysim. J Trace Elem Med Biol. 11:1997;248-252.
36. Ploplis V.A., Cornelissen I., Sandoval-Cooper M.J., Weeks L., Noria F.A., Castellino F.J. Remodeling of the vessel wall after copper-induced injury is highly attenuated on mice with a total deficiency of plasminogen activator inhibitor-1. Am J Pathol. 158:2001;107-117.